, Tracking Stock Market Picks
Enter Symbol:
Seattle Genetics, Inc. (SGEN) [hlAlert]

up 273.55 %

Seattle Genetics, Inc. (SGEN) rated Buy

Posted on: Tuesday,  Aug 21, 2007  11:25 AM ET by William Blair

William Blair rated Buy Seattle Genetics, Inc. (NASDAQ: SGEN) on 08/21/2007, when the stock price was $11.04. Since
then, Seattle Genetics, Inc. has gained 273.55% as of 01/14/2016's recent price of $41.24.
If you would have followed this William Blair's recommendation on SGEN, you would have gained 273.55% of your investment in 3068 days.

Seatlle Genetic develops monoclonal antibody-based drugs to treat cancer and related diseases. Using its monoclonal antibody-based technologies and its expertise in cancer, the company have assembled a portfolio of drug candidates targeted to many types of human cancers. The company utilizes its monoclonal antibody-based technologies to increase the potency and efficacy of antibodies with specificity for cancer. The company is testing our two most advanced product candidates, SGN-15 and SGN-10, in patients with breast, colon, prostate or other cancers.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/21/2007 11:25 AM Buy
as of 8/27/2015
1 Week down  -7.63 %
1 Month down  -16.90 %
3 Months up  2.48 %
1 YTD up  3.38 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy